C09C - search results

United States - English - NLM (National Library of Medicine)

gabapentin solution

akorn - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - gabapentin 250 mg in 5 ml - gabapentin oral solution is indicated for: gabapentin oral solution is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), such as gabapentin oral solution, during pregnancy. encourage women who are taking gabapentin oral solution during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy registry by calling the toll free number 1-888-233-2334 or visiting http://www.aedpregnancyregistry.org/. risk summary there are no adequate data on the developmental risks associated with the use of gabapentin oral solution in pregnant women. in nonclinical studies in mice, rats, and rabbits, gabapentin was developmentally toxic (increased fetal skeletal and visceral abnormalities, and increased embryofetal mortality) when administered to pregnant animals at doses similar to or lower than those used clinic

United States - English - NLM (National Library of Medicine)

gabapentin tablet, film coated

proficient rx lp - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - gabapentin tablets are indicated for: gabapentin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), such as gabapentin tablets, during pregnancy. encourage women who are taking gabapentin tablets during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy registry by calling the toll free number 1-888-233-2334 or visiting http://www.aedpregnancyregistry.org/. risk summary there are no adequate data on the developmental risks associated with the use of gabapentin tablets in pregnant women. in nonclinical studies in mice, rats, and rabbits, gabapentin was developmentally toxic (increased fetal skeletal and visceral abnormalities, and increased embryofetal mortality) when administered to pregnant animals at doses similar to or lower than those used clinically [see data]. in the u.s. general

Ireland - English - HPRA (Health Products Regulatory Authority)

eprosartan teva 300 mg film-coated tablets

teva b.v. - eprosartan mesylate - film-coated tablet - 300 milligram(s) - angiotensin ii antagonists, plain; eprosartan - angiotensin ii antagonists, plain. - it is indicated in adults for the treatment of essential hypertension.

Ireland - English - HPRA (Health Products Regulatory Authority)

eprosartan teva 400 mg film-coated tablets

teva b.v. - eprosartan mesylate - film-coated tablet - 400 milligram(s) - angiotensin ii antagonists, plain; eprosartan - angiotensin ii antagonists, plain. - it is indicated in adults for the treatment of essential hypertension.

Ireland - English - HPRA (Health Products Regulatory Authority)

eprosartan teva 600 mg film-coated tablets

teva b.v. - eprosartan mesylate - film-coated tablet - 600 milligram(s) - angiotensin ii antagonists, plain; eprosartan - angiotensin ii antagonists, plain. - it is indicated in adults for the treatment of essential hypertension.

Ireland - English - HPRA (Health Products Regulatory Authority)

teveten 400 mg, film-coated tablets

mylan ire healthcare limited - eprosartan mesylate - film-coated tablet - 400 milligram(s) - angiotensin ii antagonists, plain; eprosartan

Ireland - English - HPRA (Health Products Regulatory Authority)

teveten 600 mg, film-coated tablets

mylan ire healthcare limited - eprosartan mesylate - film-coated tablet - 600 milligram(s) - angiotensin ii antagonists, plain; eprosartan